Your Article Summary
See Latest ArticlesLong-Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
The Journal of Infectious Diseases, 07/02/09
Sacarlal J et al. - The results show evidence that RTS,S/AS02A maintained protection during the 45-month surveillance period, and they highlight the feasibility of developing an effective vaccine against malaria. In combination with other malaria-control measures, such a vaccine could greatly contribute to reducing the intolerable global burden of this disease.
Related Articles
Epidemiological Characteristics of Imported and Locally-acquired Malaria in Singapore
Annals, Academy of Medicine, Singapore, 11/03/09
Relevance Score: 94%
Are malaria treatment expenditures catastrophic to different socio-economic and geographic groups and how do they cope with payment? A study in southeast Nigeria
Tropical Medicine & International Health, 11/11/09
Relevance Score: 92%
Malaria treatment perceptions, practices and influences on provider behaviour: comparing hospitals and non-hospitals in south-east Nigeria
Malaria Journal, 10/29/09
Relevance Score: 92%
Plasmodium vivax malaria: An unusual presentation
Indian Journal of Critical Care Medicine, 10/09/09
Relevance Score: 92%
Monkey malaria kills four humans
Trends in Parasitology, 10/07/09
Relevance Score: 92%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/14/09
Factors associated with persistence of arthralgia among chikungunya virus-infected travellers: Report of 42 French cases
Journal of Clinical Virology, 12/14/09
Nanodisc-Incorporated Hemagglutinin Provides Protective Immunity against Influenza Virus Infection
Journal of Virology, 12/14/09